Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07732725Phase 1Not yet recruiting
Phase 1, randomised, double-blind trial of melatonin in sleep disorder (3 arms), sponsored by Benha University. Primary endpoint: Sleep Quality at 14 days. Planned start Aug 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07732725.